
	Where results make sense

Topic: Almirall Prodesfarma

In the News (Sat 26 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	RNS Announcements (Site not responding. Last check: 2007-10-24)
		Almirall is headquartered in Barcelona, and has a staff of over 3,200 people, approximately 500 of whom form part of the R&D team.
		Almirall is currently strengthening its direct presence in Europe and Latin America via affiliates, and is actively looking for in-licensing opportunities to support this strategy, medicines for the Central Nervous System being one of its priority areas.
		Almirall, whose Headquarters are in Barcelona (Spain), has a staff of over 3,200 people, approximately 500 of whom form part of the R&D Team.
	production.investis.com /gwpharmaceuticals/rns?id=1134370896nRNSL4716V (949 words)

	Biotechnology News and Information Portal, biotech jobs and career resources Resources.
		NBIX News announced today that it has entered into a licensing agreement\r\nwith Almirall Prodesfarma, S.A., the leading Spanish multinational\r\npharmaceutical company which is based in Barcelona, Spain, for A2A receptor\r\nantagonists for Parkinsons Disease.
		A2A is a subtype of receptors for the neuromodulator adenosine, highly co-localized with the D2 subtype of dopamine receptors in areas of the brain where a lack of the neurotransmitter dopamine produces the classic symptoms of Parkinson's disease.
		The current focus of Almirall's R and D activities are diseases such as asthma, bronchitis, allergies, atopical dermatitis and psoriasis.
	www.bioexchange.com /news/news_page.cfm?id=20809 (742 words)

	Datamonitor ComputerWire - Almirall Prodesfarma SA - Company News & Research
		Almirall Prodesfarma SA Almirall-Prodesfarma SA General Mitre, 151
		Almirall Prodesfarma, formed from the merger of Spain's two largest pharmaceutical companies, is the largest organization in the Spanish pharmaceutical industry in terms of market capitalization.
		For the fiscal year ended December 2004 Almirall Prodesfarma SA achieved revenues that totaled E900.0 million, an increase of 1.6% over the 2003 figure of E886.1 million.
	www.computerwire.com /companies/company/?pid=E5C85C59-A22A-4A76-A5B4-8CFA92AD60E4 (90 words)

	Sareum Deal with Spanish Pharma
		For further information, please visit www.sareum.co.uk About Almirall Almirall, a leading company committed to health, is a consolidated international pharmaceutical company that researches, develops and commercialises drugs from its own R&D, as well as licensed drugs, with the aim of improving health and quality of life.
		Almirall focuses its drug discovery resources in therapeutic areas related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), psoriasis and rheumatoid arthritis.
		Almirall currently has a presence in more than 100 countries with its own products and products licensed from other prestigious companies.
	www.advfn.com /news_deal-with-spanish-pharma_12131229.html (591 words)

	Sareum Ltd. Structure Based Discovery
		Almirall is an international pharmaceutical company that researches, develops and commercialises its own R&D and licensed specialities with the aim of improving health and quality of life.
		Almirall is to invest 750 million euros in R&D over the next five years.
		Almirall, whose headquarters are in Barcelona (Spain), has a staff of over 3,200 people, 500 of whom work in R&D and with approximately 1.000 working internationally in Almirall's affiliate companies.
	www.sareum.co.uk /news.htm (8517 words)

	Untitled Document (Site not responding. Last check: 2007-10-24)
		The purchase includes related industrial assets of the Almirall Group and is expected to be completed before the end of this year.
		Almirall focuses its research on therapeutic areas related to the treatment of asthma, COPD, psoriasis and rheumatoid arthritis.
		Almirall's aim is to consolidate its position by focusing on strategic business areas both through its own RandD products and through licensing agreements.
	www.emdpharmaceuticals.com /news/releases/2005_09_14.html (369 words)

	Pharmacia & Upjohn Acquires U.S. Rights to Migraine Compound From Almirall Prodesfarma
		Clinical trials for almotriptan are near completion and a New Drug Application is expected to be filed with the U.S. Food and Drug Administration by the end of this year.
		Almirall Prodesfarma is the largest pharmaceutical company in Spain and has marketing operations in other countries such as Portugal, Belgium, Mexico, Chile and Venezuela.
		Almirall Prodesfarma is a research-based company firmly set on providing innovative pharmaceutical products that contribute to improving quality of life.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/1-29-98/404572&EDATE= (292 words)

	Spanish pharmaceutical company fills prescription for improved sales with CA's CleverPath Forest & Trees (Site not responding. Last check: 2007-10-24)
		To create the system, Almirall Prodesfarma turned to 9Tres Integral Services, a CA partner with a long and successful relationship in the pharmaceutical company, and extensive experience in building business intelligence solutions.
		Almirall Prodesfarma's 700-person sales force in Spain collects business data on their laptops using a customized Lotus Notes application.
		Almirall Prodesfarma is the first Spanish pharmaceutical multinational.
	www.itweb.co.za /office/cai/0207290724.htm (889 words)

	Biotechnology news and information portal for biotechnology companies
		Profile: Almirall Prodesfarma obtains positive results in highly specific areas of research, mainly those relating to the treatment of: asthma, allergies, dermatitis and arthritis.
		Almirall Prodesfarma, S.A. is the largest organization in the Spanish pharmaceutical industry.
		The company brings together the prestige and tradition handed down from two former concerns: Grupo FarmacÃ©utico Almirall, S.A. and Grupo Prodesfarma, S.A. Our main goal is to provide society with innovative pharmaceutical products that contribute to improving the quality of life.
	directory.bioexchange.com /company_detail.cfm?co_id=1985 (146 words)

	Almirall
		By completing this form the sender expressly agrees to the automated treatment of the information included.
		Likewise, the user agrees that the personal information will remain in the company files constituting part of our business Group Almirall, in order that we may keep you informed of news and services related to the Almirall-Prodesfarma Group.
		Almirall- Prodesfarma, S.A., guarantees confidentiality of your personal information and ensures that under no circumstances will it be ceded to third parties outside our Group.
	www.almirall.es /almirall/cda/nav_eng/varios/contacto.jsp (265 words)

	European Marketing Agreement for Sativex Between GW and Almirall
		By GW Pharmaceuticals, GW and Almirall Prodesfarma, S.A. (“Almirall”) announce that they have entered into an exclusive agreement for Almirall to market Sativex® in Europe (excluding the UK).
		Dr Jorge Gallardo, President-CEO of Almirall, said: “We are very pleased with this agreement for Sativex with GW Pharmaceuticals.
		Almirall is a consolidated international pharmaceutical company that researches, develops and commercialises its own R&D and licensed specialities with the aim of improving health and quality of life.
	www.rxpgnews.com /medicalnews/healthcare/article_2987.shtml (1216 words)

	ESADE Business School > MBA, Executive Education, Undergraduate and Master in Management and Law> Barcelona, Madrid, ... (Site not responding. Last check: 2007-10-24)
		Executive Education started up this programme in July 2003, at the request of Xavier Palau and Carlos Blanquer, industrial general manager of Almirall Prodesfarma, to tackle the process of organizational change within the company.
		The Management Training and Coaching course for Almirall Prodesfarma has been developed in two stages and has dealt with in particular the team management tools and concepts, meeting management, conflict negotiation, teamwork and communication strategies.
		The complete course, comprised of 130 classroom hours, was carried out at the ESADE facilities and onsite at the Almirall Prodesfarma plant in Sant Andreu de la Barca.
	www.esade.es /src/ventana_general.php?L2RldGFsbGU=&MTQwNw== (238 words)

	Biospace.com (Site not responding. Last check: 2007-10-24)
		Sareum Ltd. (SAR.L) Release: Extension Of Collaboration With Almirall Prodesfarma
		Sareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery and services business, and Almirall Prodesfarma S.A. ("Almirall"), the leading Spanish multinational pharmaceutical company, are pleased to announce that they have extended their collaborative agreement for Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall.
		SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that it has entered into a licensing agreement with Almirall Prodesfarma, S.A., the leading Spanish multinational pharmaceutical company which is based in Barcelona, Spain, for A2A receptor antagonists for Parkinson's Disease.
	www.biospace.com /news_company.aspx?CompanyID=438115 (329 words)

	Consumers International - Almirall Prodesfarma
		Almirall states that it is committed to promoting medicines in accordance with self-regulation standards.
		The company has a code of ethics that includes ethical standards in advertising, in line with the codes of the EFPIA and the Spanish industry association Farmindustria.[1] The code focusses on interactions with healthcare professionals and other third parties[2] and includes ethical standards in advertising.[3]
		No public information was found for Almirall on competition policies.
	www.consumersinternational.org /Templates/Internal.asp?NodeID=95385 (155 words)

	Evotec (Site not responding. Last check: 2007-10-24)
		With Evotec’s state-of-the-art integrated autopurification and analytical platforms each compound will be of the highest purity to deliver high quality results in Almirall’s pharmaceutical screening and medicinal chemistry programmes.
		Almirall, a leading company committed to health, is a consolidated international pharmaceutical company that discovers, develops and commercialises drugs from its own R&D, as well as licensed drugs, with the aim of improving health and quality of life.
		Almirall focuses its drug discovery resources in therapeutic areas related to the treatment of asthma, COPD, psoriasis and rheumatoid arthritis.
	www.evotec.com /opencms/export/evotec/en/events/newsevents/21072005 (597 words)

	MAPS: med mj advance in Europe
		GW and Almirall Announce European Development and Marketing Agreement for Sativex® 12/12/2005 GW and Almirall Prodesfarma, S.A. (“Almirall”) announce that they have entered into an exclusive agreement for Almirall to market Sativex® in Europe (excluding the UK).
		Sativex is being developed by GW and is a novel prescription pharmaceutical product derived from components of the cannabis plant.
		Almirall is headquartered in Barcelona, and has a staff of over 3,200 people, approximately 500 of whom form part of the RandD team.
	www.maps.org /pipermail/maps_forum/2005-December/006954.html (777 words)

	The Protein Crystallography Information Portal - Sareum Announces Extension of Collaboration with Almirall (Site not responding. Last check: 2007-10-24)
		Almirall Prodesfarma S.A. have announced that they have extended their collaborative agreement for Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall.
		This information has been of great assistance to Almirall’s scientists in their design of improved therapeutics against inflammatory diseases.
		Commenting on the agreement, Almirall’s, Executive Director for the R&D area, Per-Olof Andersson, said, "The resolution of the crystal structure of compound-protein complexes has permitted the elucidation of the mode of binding of different compound families to the target protein."
	www.proteincrystallography.com /index.aspx?ID=74013 (266 words)

	Europe Chemicals & Chemical -- Pharmaceuticals,_biochemicals_and_intermediates&Pharmaceuticals
		Amarin Specialty pharmaceutical company that markets and sells U.S. brand name prescription and OTC drugs to high prescribing primary care and select specialty physicians through salesforce activities and via the Internet.
		Almirall Prodesfarma Almirall Prodesfarma obtains positive results in highly specific areas of research, mainly those relating to the treatment of: asthma, allergies, dermatitis and arthritis.
		Aliapharm Aliapharm represents several well known Czech manufacturers of pharmaceutical substances, intermediates and final dosage forms in Western Europe.
	www.chemnet.com /eu/dir/Pharmaceuticals,_biochemicals_and_intermediates/Pharmaceuticals/index7.html (270 words)

	Top Spanish Pharmaceutical Company Fills Prescription for Improved Sales With CA's CleverPath Forest & Trees
		The dashboard, designed and developed by CA partner 9Tres Integral Services, provides Almirall Prodesfarma's sales organization with the ability to dynamically analyze vital data from Lotus Notes, SAP and other externally processed sources -- enabling managers and salespeople to make smarter, faster business decisions.
		The ability to effectively analyze sales activity is crucial in the pharmaceutical industry, where vast information is typically gathered on the buying patterns of doctors, hospitals and other key channels.
		"We are extremely pleased with the high performance of the new system, which provides a significant competitive advantage for our company." Almirall Prodesfarma's 700-person sales force in Spain collects business data on their laptops using a customized Lotus Notes application.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-18-2002/0001766356&EDATE= (887 words)

	Information
		Almotriptan, a member of the triptan family of medications, was developed 8 years ago in Spain by the Spanish pharmaceutical company Almirall Prodesfarma.
		The Spanish Drug Agency (Agencia Española del Medicamento —AEM) and Almirall Prodesfarma have been successful in obtaining “mutual recognition” of almotriptan in 16 European countries.
		The drug, a member of the triptan family used to treat migraine, was initially approved in Spain in December 1999 and is now approved for marketing in Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Iceland, Luxembourg, Portugal, Norway, Sweden, The Netherlands and UK.
	w-h-a.org /wha2/Newsite/resultsnav.asp?idContentNews=23&color=C2D9F2 (249 words)

	Dainippon Pharmaceuticals Licenses Out an Antipsychotic Agent
		Under this License Agreement, Almirall has received the exclusive development and marketing rights of Blonanserin for the world, except Japan, China, Taiwan and South Korea.
		Blonanserin is an antipsychotic agent with novel chemical structure, which is different from the existing antipsychotic agents already launched in the market.
		Dainippon received the development and marketing rights of Almirall's original antiallergic agent "Ebastel" from Almirall under an agreement of licensing for Japan and Taiwan.
	www.asiacorpnet.com /Article.Asp?Art_ID=20752 (349 words)

	BioPharmaLink profile of Almirall-Prodesfarma SA, Spain,
		Almirall-Prodesfarma SA Almirall Prodesfarma's current workforce of 1,800 employees combines the resources of several companies dealing exclusively in the sale of pharmaceutical products: Laboratorios Berenguer-Infale, S.L., Laboratorios Farmacéuticos Almirall, S.L., Laboratorios Funk, S.L., Laboratorio Omega, Farmacéutica, S.L., Laboratorios Tecnobío, S.A., Laboratorios Farmacéuticos Prodes, S.L., Prasfarma, S.A. (in association with Asta Médica, AG).
		On the international front the company has subsidiaries in Europe (Belgium, France, Holland, Italy and Portugal) and Latin America (Colombia, Chile, Ecuador, Mexico, Peru, the Dominican Republic and Venezuela), along with sales offices worldwide.
		Almirall Prodesfarma's products are present in over 80 countries.
	biopharmalink.com /companies/1479.htm (122 words)

	Alacra Store - Almirall Prodesfarma S.A. Company Snapshot (Site not responding. Last check: 2007-10-24)
		Receive alerts on the latest reports on Almirall Prodesfarma S.A. Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies.
		Search for more premium content on Almirall Prodesfarma S.A. about us
		Reproduction in whole or in part in any form or medium without express written permission is prohibited.
	www.alacrastore.com /storecontent/companysnapshot/1086222 (97 words)

	Apria - resources - News (Site not responding. Last check: 2007-10-24)
		Barcelona, Spain - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) and Almirall Prodesfarma
		Almirall several thousand drug-like compounds across a wide range of
		Evotec as a long-term partner for this substantial library project.
	www.apria.com /resources/1,2725,494-354673,00.html (311 words)

	GW and Almirall Announce European Development and Marketing Agreement for Sativex® (Site not responding. Last check: 2007-10-24)
		GW and Almirall Prodesfarma, S.A. (“Almirall”) announce that they have entered into an exclusive agreement for Almirall to market Sativex® in Europe (excluding the UK).
		Our challenge is to improve the health and quality of life of patients suffering from MS and other debilitating conditions.”
		This news release may contain forward-looking statements that reflect GW's current expectations regarding future events, including the clinical development and regulatory clearance of its products.
	production.investis.com /gwp/pressreleases/currentpress/2005-12-12 (1063 words)

	Pharmalicensing.com: ConjuChem Enters Research Collaboration Agreement with Almirall Prodesfarma
		The agreement allows Almirall Prodesfarma to conduct pre-clinical efficacy studies with DAC:TI' over a 6-month period.
		In addition, Almirall Prodesfarma has the option to enter into exclusive negotiations for a development and commercial license to DAC:TI' during the option period.
		ConjuChem has received an option payment as per the terms of this research collaboration.
	pharmalicensing.com /company/disprelease/1009470204_3c2b4afcf413c (254 words)

	The Pharmaceutical Search Engine
		Alcala Farma's objective is to become one of the leading companies offering high quality services to the Pharmaceutical Industry.
		La mision de Almirall Prodesfarma es investigar, desarrollar y proporcionar a la sociedad productos y servicios de alta calidad y valor añadido.
		Technology driven with a focus on Speciality Pharmaceuticals.
	www.farma.com /secciones/secuk.asp?param=299 (202 words)

Try your search on: Qwika (all wikis)